CIRM asks patients how to spend last $800m for stem cell therapies
This article was originally published in Scrip
Executive Summary
The California Institute for Regenerative Medicine (CIRM) is asking patient advocates how the agency should spend the last $800m of the $3bn that the state raised through bond sales to fund stem cell research, and the answer at a recent hearing in San Diego wasn't surprising: "Spend it on me."